申请人:Henan Medinno Pharmaceutical Technology Co., Ltd.
公开号:EP3932919A1
公开(公告)日:2022-01-05
The present disclosure relates to a class of JAK inhibitor compounds and uses thereof. Specifically, the present disclosure discloses a compound represented by formula (G), isotopically labeled compound thereof, or optical isomer thereof, geometric isomer thereof, a tautomer thereof or a mixture of various isomers, or a pharmaceutically acceptable salt thereof, or a prodrug thereof, or a metabolite thereof. The present disclosure also relates to the application of the compounds in medicine.
本公开涉及一类 JAK 抑制剂化合物及其用途。具体地说,本公开涉及一种由式(G)代表的化合物、其同位素标记化合物、或其光学异构体、其几何异构体、其同分异构体或各种异构体的混合物、或其药学上可接受的盐、或其原药、或其代谢物。本公开还涉及这些化合物在医学中的应用。